The recombinant congenic mouse strains AcB55 and AcB61 are extremely resistant to malaria (Plasmodium chabaudi AS) despite the presence of susceptibility alleles at the known Char1/Char2 resistance loci. Resistance in AcB55 and AcB61 is controlled by a locus on chromosome 3 (Char4) shown to be allelic with or tightly linked to a loss-of-function mutation in pyruvate kinase (Pklr). AcB55 and AcB61 show important splenomegaly prior to infection caused by the expansion of the red pulp, and display histological signs of extramedullary erythropoiesis in the liver. Examination of splenic cell populations by flow cytometry demonstrates elevated numbers of TER119-positive erythroid precursor cells (430% of total spleen cells), while RNA expression studies show elevated expression of erythrocyte-specific transcripts such as globin, transferrin receptor, and Nramp2/Slc11a2 in the spleen of both strains. Hematological profiling in both strains is consistent with the presence of anemia as evidenced by low total erythrocyte counts, decreased hemoglobin, as well as abnormally high numbers of circulating reticulocytes (15-20%). These results strongly suggest that the mutant Pklr allele (Pklr 269A ) of AcB55/61 strains causes hemolytic anemia compensated by constitutive erythropoiesis, which in turn protects the mice against P. chabaudi infection. The possible molecular basis of the Pklr protective effect is discussed and is under current investigation in these two strains.
Introduction
The onset, progression, and ultimate outcome of many infectious diseases in humans are determined by the interplay between virulence determinants of the pathogen and genetically encoded susceptibility determinants of the host. This genetic component is often complex, multigenic, and its overall effect is variable and disease specific. 1 One of the clearest manifestations of such genetic control is malaria, where the parasite seems to have influenced the gene pool of the human host in areas of endemic disease, including retention of otherwise deleterious, disease-causing alleles at erythroid-specific genes (reviewed in Fortin et al 2 ). These include polymorphisms in the Duffy gene at the GATA-1-binding site of the chemokine receptor (DARC, also known as Fy) expressed on erythrocytes, 3 sickle cell anemia, 4 a and b thalassemia, 5, 6 glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency, 7, 8 and alterations in proteins associated with red cell integrity, such as deletions in the erythrocytic band 3 protein 9 or in the erythrocytic structural protein glycophorin C. 10 Furthermore, Class I and II HLA haplotypes 11 and genetically controlled variations in the level of the proinflammatory cytokine TNFa 12 have been shown to affect the severity and outcome of malaria. Finally, genetic linkage studies by whole genome scanning have shown that several chromosomal regions additionally affect innate susceptibility, extent of host response, and type of disease, 2 although the individual genes involved have yet to be identified.
This type of complex genetic control is difficult to study in humans and the murine model of malaria using Plasmodium chabaudi AS has proven a valuable tool. In this mouse model, genetic control of blood-stage replication of P. chabaudi AS and survival to infection are both under multigenic control. 13 Using quantitative trait linkage analyses in informative backcross and F 2 crosses derived from susceptible (A/J, C3H, SJL) and resistant (C57BL/6J) inbred mouse strains, major Chabaudi resistance (Char) loci controlling both peak parasitemia and mortality have been mapped on chromosomes 8 (Char1) and 9 (Char2), respectively. 14, 15 A third H-2 linked locus, Char3, on chromosome 17 was also mapped, which regulates blood parasite clearance, immediately following peak parasitemia. 16 Recently, we have used recombinant congenic strains (RCS) of mice to identify novel genetic loci controlling susceptibility to P. chabaudi infection. The AcB/BcA panel of RCS mice was derived from P. chabaudi AS susceptible A/J (A) and resistant C57BL/6 (B6) mice by systematic inbreeding of pairs of [(A Â B) Â A] Â A and of [(A Â B) Â B] Â B double backcross N3 mice. 17 An initial phenotypic survey of 18 AcB/BcA strains, using level of blood parasitemia at the peak of infection and overall survival as measures of susceptibility, showed that resistance and susceptibility in these strains mostly followed haplotype combinations at Char1 and Char2 loci. 18 However, two AcB strains, AcB55 and AcB61 were found to be highly resistant to infection despite the presence of 83% of A/J-derived genome including susceptibility alleles at Char1 and Char2. Following intraperitoneal (i.p.) infection with 10 6 P. chabaudi AS parasitized red blood cells (pRBCs), AcB55/AcB61 mice show a rapid rise in parasitemia during the first 5-6 days postinfection, with peak parasitemia occurring by days 7-8 (35-43% pRBCs in AcB55; 31-39% pRBCs in AcB61). There is a rapid resolution of parasitemia by day 12 postinfection, with no mortality in either strain. 13 Compared to the resistant B6 strain, AcB55 and AcB61 mice have significantly lower peak parasitemia, clear the infection about 2-3 days earlier, and have fewer physical symptoms during acute parasitemia. Linkage analysis in 200 mice from informative (AcB55 Â A)F2 population genotyped for segregation of informative, B6-derived congenic chromosomal segments, and using peak parasitemia as a quantitative trait, located a novel B6-derived resistance locus on chromosome 3 (LOD ¼ 6.57) that we designated Char4. 18 A second, suggestive linkage on chromosome 10 (LOD ¼ 2.53) showed an additive effect with Char4 on peak parasitemia. Recently, we have shown that the protective effect of Char4 is tightly linked or identical to a loss-of-function mutation at the erythrocyte and liver-specific isoform of pyruvate kinase (Pklr 269A ). Segregation analyses showed that homozygosity for Pklr 269A was associated with reduced parasitemia at the peak of infection and increased survival following infection with P. chabaudi.
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In the present report, we have investigated the phenotypic expression of the loss-of-function Pklr allele (Pklr 269A ) at the organ, tissue, and cellular level with special emphasis on the erythroid compartment, the site of Plasmodium replication in vivo.
Results
During blood-stage P. chabaudi AS infection, we observed that AcB55 mice develop an important splenomegaly with a spleen index (SI) of 1.8 at day 7 ( Figure 1) . Although splenomegaly is a normal response to acute P. chabaudi AS infection in mice, the splenomegaly seen in AcB55 was far superior to that seen in malariasusceptible A/J (SI ¼ 1.15) and malaria-resistant B6 controls (SI ¼ 0.9) examined at day 7 postinfection. Interestingly, we noticed that AcB55 mice showed marked splenomegaly even in the absence of P. chabaudi infection (Figure 1a) , with an SI of 1.2 compared to A/J (0.53) and B6 (0.6) controls (Figure 1b ). This splenomegaly was observed in malaria-resistant AcB61 mice as well, both prior to and during P. chabaudi infection (Figures 1b and c) . Thus, pyruvate kinase deficiency (Pklr 269A ) and protection against malaria in AcB55 and AcB61 are associated with constitutive splenomegaly.
Spleens from individual AcB55 and control A/J mice were harvested, and fixed sections were subjected to histological analysis (Figure 2a) . Examination of spleen sections under low magnification identified significant changes in the architecture of AcB55 spleen, most notably an important expansion of the red pulp. Overall, AcB55 showed an obvious increase in the ratio of red to white pulp when compared to A/J controls. In mice, the red pulp is the site of filtration, sequestration, and macrophage-mediated elimination of effete red cells, but is also an important site of hematopoiesis, while the white pulp, situated around central arteries, is part of the lymphoid system. 20 Analysis of spleen sections from A/J and AcB55 mice 7 days following P. chabaudi infection showed a further expansion of the red pulp and further increase in red:white pulp ratios in both strains (data not shown). Parallel studies of liver sections identified additional changes in AcB55. When compared to A/J controls, AcB55 sections showed small clusters of nucleated cells among hepatocytes and bordering blood vessels. This was observed for several blood vessels on the same section (Figure 2b ). At higher magnification (Figures 2c and d) , cells resembling erythrocytes were clearly seen among these cell clusters in the interstitial space outside the blood vessel (Figures 2c and d) . The appearance of such cellular aggregates in the liver, together with expansion of the red pulp compartment in the spleen, is compatible with the presence of extramedullary hematopoiesis in AcB55 mice. Similar results were obtained with AcB61 (data not shown).
A complete analysis of hematological parameters of A/J, C57BL/6J, AcB61, and AcB55 mice was conducted. This analysis identified several changes specific to AcB55/61 strains. A decrease of close to 20% in the number of erythrocytes was noted in peripheral blood from both AcB55/61 (RBCs; 7.2-8.2 Â 10 12 /l) when Table 1 ). This was concomitant with a decrease in total hemoglobin (134-144 vs 156-168 g/l) and a parallel increase in mean corpuscular volume (MCV; 54.5-57.5 vs 46.5-48.3 fL). Furthermore, while the distribution of other cell types in circulating blood, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils, was similar to that of A/J and B6 controls (WBCs; see Table 1 ), AcB55/61 were found to have a significantly higher percentage (11-21%) of reticulocytes, compared to A/J (4%) and B6 (4%) (Po0.001) (shown in Figure 3 ). Together, these results suggest the presence of anemia in AcB55 and AcB61 mice concomitant to extramedullar hematopoiesis in the liver and increased numbers of reticulocytes in peripheral blood. Finally, infection with P. chabaudi AS results in a further increase in the number of reticulocytes in A/J, B6, and AcB55 reaching 7, 15, and 36% by day 9 postinfection, respectively ( Figure 3c ). Therefore, P. chabaudi AS infection exacerbates the anemic status of AcB55/61 by day 9 postinfection. It is interesting to note that at that time AcB55/61 mice have nevertheless achieved complete parasite clearance from peripheral blood.
We further investigated the cellular composition of the spleen by FACS analysis, using cell surface markers specific for cells of the lymphoid, myeloid, and erythroid lineages ( Table 2 ). Single-cell suspensions were prepared from the spleen of uninfected AcB55, AcB61, and control A/J and B6 mice, and analyzed for surface markers expressed on mononuclear phagocytes (Mac1), T-lymphocytes (CD3, CD4, CD8), B-lymphocytes (B220), NK cells (PanNK), and erythroid cells (TER119). Results in Table 2a show that AcB55 had a higher number of CD3 þ and CD4 þ cells (compared to A/J, not B6), but there was no imbalance in the CD4:CD8 ratio in the total CD3 þ T-cell population in AcB55 compared to A/J or B6. Most strikingly, however, AcB55 showed an unusually high percentage of TER119 þ cells (41.3 Â 10 6 cells/spleen; B30% of total spleen cells) compared to both A/J and B6 (2.2-3.8 Â 10 6 cells/spleen; 4-5% total) controls. This represents a 10-fold increase in the number of TER119 þ cells in AcB55 compared to either A/J or B6. Similar results were observed with spleen cell populations from uninfected AcB61 mice (49 Â 10 6 cells/spleen; 35% total). The dramatic increase in TER119 þ cells in both AcB55 and AcB61 is clearly displayed in the flow cytometry dot plots in Figure 4 . Since TER119 is a marker expressed on committed erythroid cells well into their differentiation to become erythrocytes, these results strongly suggest the expansion of the erythroid compartment in AcB55/61. Spleen cell populations from the same mice were also examined 7 days following P. chabaudi AS infection. The total cellularity of spleens from all strains increased significantly, reflecting important infection-induced splenomegaly. This increase affected all compartments, but did not markedly alter the relative proportion of each cell population when compared to uninfected spleen. Again, AcB55 and AcB61 had three-to four-fold more TER119 þ cells than B6 and seven-to nine-fold more TER119 þ cells than A/J (Table 2b) .
The apparent increase in erythroid activity noted in the spleen of AcB55/61 mice by FACS analysis was further investigated by gene expression studies. We isolated total RNA from spleens of noninfected mice, and analyzed it by Northern blotting. For these experiments, expression of a-globin, transferrin receptor, and Nramp2/Slc11a2 Pklr deficiency and protection against malaria G Min-Oo et al mRNAs (known markers of the erythroid lineage) was compared in AcB55, AcB61, A/J, and B6. In this analysis, equal amounts of total spleen RNA were loaded on gel, transferred to a hybridization membrane, followed by probing with [ 32 P]-labeled cDNAs. Results in Figure 5 show a notable increase in the expression of the three transcripts in the spleen of AcB55/61 when compared to either A/J or B6. These results indicate enhanced expression of erythroid-specific genes in the spleen of AcB55/61 mice.
Taken together, our results show that Pklr deficiency and resistance to malaria in AcB55/61 mice is linked to a common anemia phenotype characterized by splenomegaly, expansion of the TER119 þ erythroid compartment in the red pulp, and elevated numbers of reticulocytes in peripheral blood.
Discussion
In the present study, we show that the Pklr 269A mutation identified in AcB55/61, and closely linked to a unique Char1/Char2-independent resistance to malaria, results in a set of distinct subphenotypes in the erythroid compartment. These include enlargement of the spleen caused by the expansion of the red pulp and an elevated number of reticulocytes in peripheral blood, constitutively present and exacerbated by P. chabaudi AS infection. We also observed an increased number of TER119 þ erythroid precursor cells in the spleen, and noted histological signs of extramedullary hematopoiesis in the liver, suggesting expansion of the erythroid compartment in both strains. This was verified by RNA expression studies that demonstrated increased expression of erythroid-specific transcripts in the spleen of AcB55/61. Finally, hematological analyses showed a reduced number of erythrocytes and decreased hemoglobin in AcB55/61. A similar hematological profile was described by Morimoto et al, 21 in the CBA-Pk-1 slc mouse model of PK deficiency. From these observations, we conclude that PK deficiency in AcB55/61 mice causes a form of hemolytic anemia, associated with compensatory extramedullar erythropoiesis and reticulocytosis. This pleiotropic effect, either directly or indirectly, protects mice against malaria. These results raise the intriguing possibility that pyruvate kinase deficiency may similarly protect humans against malaria.
Red cell disorders in humans, many of which result in a hemolytic anemia, have been extensively documented to show a protective effect against malaria (reviewed in Likewise, increased resistance to malaria has been demonstrated in mice deficient for the red cell proteins ankyrin and spectrin. 24 Several mechanisms including reduced invasion, impairment of parasite growth, and enhanced removal of the parasitized RBC variants have been proposed to account for protective effects of hemoglobinopathies, although exact mechanisms have not been deciphered. 25 In the case of thalassemia, parasitized erythrocytes may be more prone to ingestion by macrophages, while HbS and HbE variants could Pklr deficiency and protection against malaria G Min-Oo et al impair parasite entry and subsequent growth in erythrocytes. HbS, HbE, and the b-thalassemias appear to be protective against malaria in the heterozygous state, while for a þ -thalassemia and the HbC (b 6Glu-Lys ) variant, protection against malaria is seen in both heterozygotes and homozygotes, and is most pronounced in homozygotes. 26, 27 In the case of HbC, the mechanism of protection has been associated with reduced permissiveness of HbC erythrocytes to parasite replication. 28 G6PD deficiency, which can result in stress-induced hemolysis, also appears to protect against malaria in the heterozygous and hemizygous states. 29 The protective effect of G6PD deficiency may be caused by the reduction of intracellular parasite growth, increased elimination of infected RBCs, and increased fragility to malaria-induced oxidative damage. 8 Our studies in mice raise the possibility that PK deficiency in humans may also offer protection against malaria. In erythrocytes, pyruvate kinase is absolutely required for glucose metabolism and ATP generation in the absence of mitochondrial respiration. Hereditary nonspherocytic hemolytic anemia is the condition resulting from homozygosity or compound heterozygosity at PKLR mutations, and ranges in severity from mild to lifethreatening hemolysis. 30 Over 100 mutations have been identified spanning the entire gene, but no definite associations have been made between the severity of the phenotype and the position of the mutation. The mechanism by which the enzyme deficiency results in hemolytic anemia is unclear, but is likely to involve ATP depletion, shortened red cell lifespan, and/or build up of pyruvate precursors. 31 The malaria protective effect of pyruvate kinase deficiency and the resulting hemolytic anemia may involve mechanisms similar to those seen in other red Table 2 Distribution of cell types in the spleen: cell disorders, as described above. The early destruction of PK-deficient cells by the reticuloendothelial system may prematurely remove from the circulation infected and uninfected erythrocytes alike, thereby limiting parasite replication at an early stage. Constitutive hemolysis also induces an increased erythropoietic response, as is evident in this study, and P. chabaudi may have a slight preference for mature as opposed to young red cells and/or reticulocytes, resulting in a selflimiting infection. Interestingly, increased levels of 2,3-DPG (a metabolic intermediate upstream PK) that are found in PK-deficient RBCs may in turn inhibit certain metabolic pathways of the parasite, 32 and indirectly increase concentrations of oxidative species through the inhibition of G6PD, 33 creating a less hospitable environment for parasite development. Finally, because of the essential nature of PK for parasite metabolism, the deficiency of the host enzyme may hinder parasite growth at the early stages of infection. However, elevated PK activity in infected erythrocytes is believed to be contributed almost entirely by the parasite-encoded enzyme. 34 The AcB55 and AcB61 strains described herein provide a unique opportunity to further study the physiological and molecular basis by which PK-deficiency-induced hemolytic anemia causes resistance to malaria. These may in turn suggest novel targets and pathways for therapeutic intervention in this disease.
Materials and methods
Mice and parasite A/J mice (A) were purchased from the Jackson Laboratories (Bar Harbor, ME, USA) and C57BL/6 (B6) mice were purchased from Charles River Laboratories (St Constant, Quebec, Canada). The AcB/BcA panel of RCS was generated according to a breeding scheme described by Demant and Hart, 35 and have been genotyped for over 600 informative markers. 17 All mice were maintained and handled according to guidelines of the Canadian Council on Animal Care. P. chabaudi AS was passaged in vivo as described previously. 36 Mice were infected by the i.p. route with 10 6 pRBCs, and the degree of blood parasitemia was monitored during the course of infection at the times indicated using previously established methods. 36 In some experiments, mice were killed at different times following infection, and organs were collected and photographed. The spleen was weighed and the SI was calculated as the root square of spleen weight ( Â 100) divided by the body weight.
Histology
Spleens and livers of AcB55, AcB61, as well as control A/J and C57BL/6 mice were harvested for histology. Fresh organs were fixed in Bouin's solution (picric acid 9 g/l, acetic acid 4%, and formaldehyde 25%) for 72 h at 201C, followed by dehydration in a series of ethanol solutions (3 Â 20 min: 70, 95, and 100%), ethanol/xylene (1:1), xylene, followed by embedding in paraffin. Sections (5 mm) were prepared and mounted on glass slides, followed by deparaffinization in xylene, and rehydration in a graded series of ethanol baths (100, 95, 70, 50, and 30%). The slides were then incubated in phosphatebuffered saline (PBS) and stained with hematoxylin and eosin, then dehydrated in ethanol and xylene, and mounted in Permount. The sections were examined and photographed with a Nikon microscope using Â 10, Â 40, and Â 100 objectives.
Hematologic parameters
All AcB and BcA strains underwent a complete analysis of hematological parameters in peripheral blood, including erythrocyte and leukocyte counts, hemoglobin, hematocrit, platelets, MCV, and MCH (mean concentration of hematocrit) (Diagnostic and Research Support Service, Animal Resources Centre, McGill University). In addition, fresh peripheral blood was collected from tail veins, diluted 1:200 in 1 Â PBS, and the numbers of erythrocytes were enumerated microscopically using a hemocytometer. The percentage of reticulocytes was determined by differential counts based on 400 cells on thin blood smears stained with Diff-Quik s (Dade Behring, Switzerland). 37 Flow cytometry Single-cell suspensions were prepared for flow cytometry essentially as described previously. 38 Briefly, spleens Figure 5 Increased expression of erythroid-specific transcripts in the spleen and liver of AcB55 and AcB61 mice. Total cellular RNA extracted from spleen of AcB55, AcB61, and control B6 and A/J mice were separated by gel electrophoresis (20 mg) and transferred to a hybridization membrane, followed by hybridization to cDNA probes for several erythroid-specific genes, a-globin, transferrin receptor, and Nramp2 (Slc11a2).
were minced and pressed gently through a wire mesh. ) resuspended in 50 ml of sorting buffer (PBS supplemented with 1% fetal calf serum and 0.05% sodium azide) were incubated first with 1 mg of purified anti-mouse CD16/ CD32 to block nonspecific binding by Fc receptors for 20 min at 41C and stained with 2 mg of FITC-or PEconjugated mAb or control mAb for 30 min at 41C in the dark. After two washes, cells were resuspended in 0.5 ml of sorting buffer and analyzed immediately on FACScan (BD BioSciences, Mississauga, Ontario, Canada). Cell acquisitions and data analyses were performed using CellQuest software (BD BioScience, Mississauga, Ontario, Canada). Results for each marker are presented as the total number of positively stained cells per spleen.
RNA isolation
Total cellular RNA was extracted from the spleen and liver using a commercial TRIZOL reagent and following the manufacturer's recommended protocol (Invitrogent, Burlington, Ontario, Canada). Tissues were snap frozen in liquid nitrogen, and 100 mg of tissue was homogenized by mechanical disruption with a Polytront (Brinkmann Instruments, Mississauga, Ontario, Canada), in a final 1 ml volume of TRIZOL reagent. The samples were incubated for 5 min at RT, followed by chloroform extraction. The aqueous phase was removed and nucleic acids were precipitated with isopropanol. Pellets were washed with 75% ethanol, and dissolved in ribonucleasefree water treated with diethlypyrocarbonate (0.1%). The quality of RNA preparations was verified by electrophoresis on formaldehyde-containing agarose gel prior to use.
Northern blot analysis
Aliquots of 20 mg of total splenic RNA were resolved by electrophoresis in a 1% agarose denaturing gel containing 8% formaldehyde. The RNA was transferred onto a Hybond-N (Amersham, Baie d'Urfe, Quebec, Canada) nylon membrane following the manufacturer's instructions and fixed to the membrane by UV crosslinking. The membranes were prehybridized in buffer containing 1% sodium dodecyl sulfate, 1 M NaCl, 10% dextran sulfate, and 100 ng/ml of heat denatured salmon sperm DNA (16 h at 651C). Membranes were hybridized (16 h at 651C) in the same buffer containing radiolabeled probes (1 Â 10 6 cpm/ml). Blots were washed in a series of buffer conditions of increasing stringency, up to 0.1 Â SSC (20 Â SSC is 3 M sodium chloride, 0.3 M sodium citrate, pH 7.0) and 0.5% SDS (1 h at 651C), and exposed to Kodak XAR films (À801C) with intensifying screens. Hybridization probes included cDNAs for a-globin, transferrin receptor, and Nramp2. The 564 bp a-globin probe was PCR amplified as full-length cDNA from a pSPORT1 plasmid clone (gift from Dr D Housman, MIT, Cambridge, MA, USA), using vector primers (5 0 )CCAGTCACGACGTTGTAAAACGAC(3 0 ) and (5 0 )GTGTGGAATTGTGAGCGGATAACAA(3 0 ). The transferrin receptor probe was an 888 bp cDNA fragment obtained by reverse transcription and PCR amplified from spleen RNA. Briefly, total cDNA was synthesized from AcB55 and A/J spleen RNA using M-MLV reverse transcriptase (Invitrogen, Burlington, Ontario, Canada) primed with random hexamers (Amersham Pharmacia Biotech, Baie d'Urfe, Quebec, Canada). The transferrin receptor cDNA fragment was amplified using the PCR primers (5 0 )GGACATGCTCATCTAGGAACTG(3 0 ) and (5 0 )CCACTTCCGCTGCTGTACGA(3 0 ). A previously described full-length cDNA clone for Nramp2 was also used. 39 
Statistical analysis
All studies were repeated two or more times with three to five animals per group. Statistical significance between groups was tested by a two-sample Student's t-test. A Pvalue of 0.05 or less was considered significant. All statistical analyses were performed using SAS-STAT software (Cary, NC, USA).
